Largest pharmaceuticals by earnings
Net income for the latest fiscal year: what was left for shareholders after every cost, interest and tax. A negative figure is a loss.
Johnson & Johnson leads the 61 pharmaceuticals ranked by earnings, at ZAR 460.9B, ahead of Eli Lilly (ZAR 354.9B) and Merck & Co (ZAR 313.9B). Figures as of 18 Nov 2026, 15:06 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 61
- First
- Johnson & JohnsonZAR 460.9B
- Median
- ZAR 1B
- Combined market value
- ZAR 88.19T
- Countries
- 10
Market values as of .
All countries▾
All sectors▾
Pharmaceuticals▾
| # | Company | Earnings ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | Johnson & JohnsonJNJ · Health Care | ZAR 460.9B | ZAR 11.47T | ZAR 4,765.48 | 0.56% down | 38% up | ||
| 2 | Eli LillyLLY · Health Care | ZAR 354.9B | ZAR 21.47T | ZAR 24,103.31 | 0.98% down | 35% up | ||
| 3 | Merck & CoMRK · Health Care | ZAR 313.9B | ZAR 6T | ZAR 2,433.55 | 1.29% down | 51% up | ||
| 4 | Novo NordiskNVO · Health Care | ZAR 261.4B | ZAR 3.05T | ZAR 691.10 | 1.25% down | 17% down | ||
| 5 | NovartisNVS · Health Care | ZAR 240.5B | ZAR 5.11T | ZAR 2,704.90 | 1.15% down | 25% up | ||
| 6 | AstraZenecaAZN · Health Care | ZAR 175.8B | ZAR 4.81T | ZAR 3,102.30 | 1.02% down | 2% up | ||
| 7 | SanofiSNY · Health Care | ZAR 149.1B | ZAR 1.96T | ZAR 817.83 | 0.06% up | 4% down | ||
| 8 | PfizerPFE · Health Care | ZAR 133.6B | ZAR 2.77T | ZAR 486.73 | 0.58% down | 14% up | ||
| 9 | GSKGSK · Health Care | ZAR 130.5B | ZAR 1.69T | ZAR 845.18 | 0.18% down | 6% up | ||
| 10 | Bristol-Myers SquibbBMY · Health Care | ZAR 121.3B | ZAR 2.13T | ZAR 1,043.19 | 1.12% down | 34% up | ||
| 11 | Abbott LaboratoriesABT · Health Care | ZAR 112.2B | ZAR 3.12T | ZAR 1,803.33 | 0.15% up | 17% down | ||
| 12 | Regeneron PharmaceuticalsREGN · Health Care | ZAR 77.5B | ZAR 1.71T | ZAR 16,538.61 | 0.42% up | 36% up | ||
| 13 | AbbVieABBV · Health Care | ZAR 72.7B | ZAR 8.84T | ZAR 5,003.56 | 0.63% down | 26% up | ||
| 14 | Vertex PharmaceuticalsVRTX · Health Care | ZAR 68B | ZAR 2.36T | ZAR 9,308.06 | 1.33% up | 27% up | ||
| 15 | ZoetisZTS · Health Care | ZAR 46B | ZAR 585.1B | ZAR 1,439.98 | 0.31% up | 29% down | ||
| 16 | Teva Pharmaceutical IndustriesTEVA · Health Care | ZAR 24.2B | ZAR 860.2B | ZAR 737.19 | 0.59% up | 74% up | ||
| 17 | United TherapeuticsUTHR · Health Care | ZAR 23B | ZAR 425.1B | ZAR 9,980.37 | 0.63% down | 23% up | ||
| 18 | GenmabGMAB · Health Care | ZAR 16.6B | ZAR 548.2B | ZAR 889.02 | 0.50% down | 70% up | ||
| 19 | Royalty PharmaRPRX · Health Care | ZAR 13.3B | ZAR 681B | ZAR 1,184.45 | 0.29% up | 78% up | ||
| 20 | PTC TherapeuticsPTCT · Health Care | ZAR 11.7B | ZAR 87.1B | ZAR 1,042.41 | 0.43% up | 20% down | ||
| 21 | Dr. Reddy's LaboratoriesRDY · Health Care | ZAR 7.8B | ZAR 214.7B | ZAR 257.51 | 1.18% up | 5% up | ||
| 22 | TG TherapeuticsTGTX · Health Care | ZAR 7.7B | ZAR 166.2B | ZAR 1,099.50 | 1.96% up | 107% up | ||
| 23 | GrifolsGRFS · Health Care | ZAR 7.7B | ZAR 100.6B | ZAR 147.88 | 0.35% down | 1% up | ||
| 24 | BioMarin PharmaceuticalBMRN · Health Care | ZAR 6B | ZAR 197.5B | ZAR 1,019.88 | 1.37% up | 11% up | ||
| 25 | Alnylam PharmaceuticalsALNY · Health Care | ZAR 5.4B | ZAR 359.3B | ZAR 2,682.81 | 0.31% down | 66% down | ||
| 26 | BeOne MedicinesONC · Health Care | ZAR 4.9B | ZAR 798.2B | ZAR 6,987.96 | 1.67% down | 17% up | ||
| 27 | AlkermesALKS · Health Care | ZAR 4.2B | ZAR 133.9B | ZAR 797.11 | 1.99% up | 58% up | ||
| 28 | Ligand PharmaceuticalsLGND · Health Care | ZAR 2.1B | ZAR 101.9B | ZAR 5,096.50 | 0.87% up | 43% up | ||
| 29 | Corcept TherapeuticsCORT · Health Care | ZAR 1.7B | ZAR 131.9B | ZAR 1,205.17 | 0.02% up | 8% down | ||
| 30 | Amneal PharmaceuticalsAMRX · Health Care | ZAR 1.2B | ZAR 128.9B | ZAR 370.05 | 1.89% up | 83% up | ||
| 31 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | ZAR 1B | ZAR 130.5B | ZAR 1,661.29 | 1.58% up | 126% up | ||
| 32 | Arrowhead PharmaceuticalsARWR · Health Care | -ZAR 28M | ZAR 106.2B | ZAR 751.46 | 1.65% up | 10% up | ||
| 33 | Mirum PharmaceuticalsMIRM · Health Care | -ZAR 401.7M | ZAR 103.3B | ZAR 1,582.27 | 0.07% up | 31% up | ||
| 34 | Travere TherapeuticsTVTX · Health Care | -ZAR 439.3M | ZAR 83.8B | ZAR 873.08 | 0.64% down | 44% up | ||
| 35 | VeradermicsMANE · Health Care | -ZAR 1.2B | ZAR 92B | ZAR 2,180.78 | 0.94% up | 233% up | ||
| 36 | Belite BioBLTE · Health Care | -ZAR 1.3B | ZAR 110.3B | ZAR 2,715.92 | 0.14% up | 31% up | ||
| 37 | Oruka TherapeuticsORKA · Health Care | -ZAR 1.8B | ZAR 114.3B | ZAR 1,685.36 | 1.75% up | 241% up | ||
| 38 | ErascaERAS · Health Care | -ZAR 2.1B | ZAR 81.7B | ZAR 232.92 | 2.48% down | 403% up | ||
| 39 | Protagonist TherapeuticsPTGX · Health Care | -ZAR 2.2B | ZAR 141.4B | ZAR 2,166.24 | 1.05% up | 46% up | ||
| 40 | Spyre TherapeuticsSYRE · Health Care | -ZAR 2.7B | ZAR 156.7B | ZAR 1,650.46 | 2.31% up | 286% up | ||
| 41 | Dianthus TherapeuticsDNTH · Health Care | -ZAR 2.8B | ZAR 85.2B | ZAR 1,512.72 | 1.14% up | 113% up | ||
| 42 | Edgewise TherapeuticsEWTX · Health Care | -ZAR 2.9B | ZAR 78.3B | ZAR 714.92 | 1.11% down | 88% up | ||
| 43 | Axsome TherapeuticsAXSM · Health Care | -ZAR 3.1B | ZAR 122.1B | ZAR 2,321.44 | 0.70% down | 7% down | ||
| 44 | Definium TherapeuticsDFTX · Health Care | -ZAR 3.2B | ZAR 69.6B | ZAR 508.05 | 0.56% up | 169% up | ||
| 45 | Rhythm PharmaceuticalsRYTM · Health Care | -ZAR 3.4B | ZAR 138.7B | ZAR 2,000.48 | 0.24% down | 13% up | ||
| 46 | Elanco Animal HealthELAN · Health Care | -ZAR 4B | ZAR 226.2B | ZAR 452.59 | 1.82% up | 20% up | ||
| 47 | Ascendis PharmaASND · Health Care | -ZAR 4.4B | ZAR 306B | ZAR 4,664.37 | 0.02% up | 28% up | ||
| 48 | Madrigal PharmaceuticalsMDGL · Health Care | -ZAR 5B | ZAR 167.9B | ZAR 7,229.13 | 0.38% down | 24% down | ||
| 49 | Legend BiotechLEGN · Health Care | -ZAR 5.1B | ZAR 54.8B | ZAR 282.53 | 1.99% up | 42% down | ||
| 50 | Roivant SciencesROIV · Health Care | -ZAR 5.2B | ZAR 487.7B | ZAR 673.04 | 1.11% up | 90% up | ||
| 51 | Praxis Precision MedicinesPRAX · Health Care | -ZAR 5.2B | ZAR 149.4B | ZAR 5,346.36 | 1.92% up | 61% up | ||
| 52 | Cogent BiosciencesCOGT · Health Care | -ZAR 5.7B | ZAR 84.8B | ZAR 487.50 | 1.80% up | 20% down | ||
| 53 | Jazz PharmaceuticalsJAZZ · Health Care | -ZAR 6.1B | ZAR 268B | ZAR 4,175.75 | 0.88% up | 37% up | ||
| 54 | ABIVAXABVX · Health Care | -ZAR 6.4B | ZAR 126.4B | ZAR 1,443.85 | 2.27% up | 27% down | ||
| 55 | Ionis PharmaceuticalsIONS · Health Care | -ZAR 6.6B | ZAR 78.4B | ZAR 470.99 | 1.59% up | 64% down | ||
| 56 | BridgeBio PharmaBBIO · Health Care | -ZAR 12.6B | ZAR 260.5B | ZAR 1,337.15 | 1.25% up | 17% up | ||
| 57 | CytokineticsCYTK · Health Care | -ZAR 13.5B | ZAR 125.9B | ZAR 903.98 | 1.78% up | 20% down | ||
| 58 | Takeda PharmaceuticalTAK · Health Care | -ZAR 16.4B | ZAR 1.18T | ZAR 369.88 | 0.60% down | 54% up | ||
| 59 | Summit TherapeuticsSMMT · Health Care | -ZAR 18.6B | ZAR 155.4B | ZAR 194.36 | 5.93% up | 36% down | ||
| 60 | InsmedINSM · Health Care | -ZAR 22B | ZAR 460B | ZAR 2,096.69 | 0.06% up | 40% down | ||
| 61 | ViatrisVTRS · Health Care | -ZAR 60.4B | ZAR 408B | ZAR 355.87 | 1.20% up | 96% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Earnings is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 17.1958 ZAR).
Questions and answers
Which pharmaceuticals rank first by earnings?
Johnson & Johnson (ZAR 460.9B), Eli Lilly (ZAR 354.9B) and Merck & Co (ZAR 313.9B) are the top three of the 61 pharmaceuticals ranked by earnings as of 18 Nov 2026, 15:06 UTC.
How many pharmaceuticals are in this ranking?
61 are ranked by earnings.
What are these pharmaceuticals worth together?
The 61 pharmaceuticals ranked by earnings have a combined market value of ZAR 88.19T as of 18 Nov 2026, 15:06 UTC.
What does ranking by earnings measure?
Net income for the latest fiscal year: what was left for shareholders after every cost, interest and tax. A negative figure is a loss.
Learn how this ranking works
All markets guides →- Revenue vs earnings vs free cash flow: what each tells you
Revenue is everything a company sold in a period. Earnings, or net income, is what remains after every cost, interest and tax. Free cash flow is the cash operations brought in minus spending on long-lived assets. Revenue shows size and demand, earnings show profitability, and free cash flow shows how much cash the business can actually hand out.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
- How companies are sorted into sectors and industries
Companies are sorted into sectors and industries by classification systems. The index providers MSCI and S&P Dow Jones Indices use GICS: 11 sectors split into 25 industry groups, 74 industries and 163 sub-industries. SEC filings carry a four-digit SIC code. The two can place one company differently, because each looks at the business from its own angle.
Cite this page
Funkfolio, “Largest pharmaceuticals by earnings”, data as of 18 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?by=earnings
Underlying data: Yahoo Finance; SEC EDGAR.